betamethasone has been researched along with Ataxia Telangiectasia in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (33.33) | 29.6817 |
| 2010's | 7 (58.33) | 24.3611 |
| 2020's | 1 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Barone, MV; Cirillo, E; Del Vecchio, L; Gallo, V; Giardino, G; Magnani, M; Menotta, M; Palamaro, L; Pignata, C; Prencipe, R; Scalia, G | 1 |
| Cappellari, AM; Cirillo, E; Del Giudice, E; Dell'Era, L; Dellepiane, RM; Micheli, R; Pession, A; Pietrogrande, MC; Pignata, C; Plebani, A; Soresina, A; Specchia, F | 1 |
| Fujine, A; Hasegawa, S; Hasegawa, T; Hayashi, M; Hisakawa, H; Hosokawa, T; Imai, K; Kashimada, A; Kashimada, K; Kumada, S; Mashimo, H; Miyata, R; Miyata, Y; Mizuno, T; Mizutani, S; Morio, T; Moriyama, K; Nishida, H; Sakuma, H; Shirai, I; Sugawara, Y; Takagi, M; Tanuma, N; Tsuji-Hosokawa, A; Uematsu, M | 1 |
| Barnett, NL; Bellingham, MC; Cheung, K; Dingwall, S; Gatei, M; Kozlov, S; Lavin, MF; Lee, CS; Lim, YC; Luff, J; Mashimo, T; Noakes, PG; Quek, H; Roberts, TL; Wolvetang, E | 1 |
| Gatti, RA; Perlman, S | 1 |
| Aloj, G; Amorosi, S; Broccoletti, T; Cirillo, E; Cosentino, C; Costanzo, V; Del Giudice, E; Fusco, A; Pignata, C; Russo, I | 1 |
| Broccoletti, T; Bruscoli, S; Cirillo, E; Del Giudice, E; Giardino, G; Ginocchio, VM; Pignata, C; Riccardi, C; Vigliano, I | 1 |
| Aloj, G; Carotenuto, B; Cirillo, E; Del Giudice, E; Giardino, G; Marsili, A; Pignata, C; Prinster, A; Quarantelli, M; Salvatore, E | 1 |
| Betti, G; Brusco, A; Buoni, S; Chessa, L; Finocchi, A; Fois, A; Hayek, J; Kelly, C; Leuzzi, V; Martino, S; Micheli, R; Misiani, F; Pietrogrande, MC; Plebani, A; Rossi, LN; Salvucci, S; Soresina, A; Zannolli, R | 1 |
| Esposito, T; Fusco, A; Gallo, V; Giardino, G; Maio, F; Palamaro, L; Parenti, G; Pignata, C; Romano, R; Salerno, MC; Vajro, P | 1 |
| Buoni, S; Fois, A; Sorrentino, L; Zannolli, R | 1 |
| Amorosi, S; Broccoletti, T; Del Giudice, E; Di Bonito, M; Imperati, F; Pignata, C; Romano, A; Russo, I | 1 |
1 review(s) available for betamethasone and Ataxia Telangiectasia
| Article | Year |
|---|---|
Betamethasone therapy in ataxia telangiectasia: unraveling the rationale of this serendipitous observation on the basis of the pathogenesis.
Topics: Ataxia Telangiectasia; Ataxia Telangiectasia Mutated Proteins; Betamethasone; Cell Cycle Proteins; DNA-Binding Proteins; Glucocorticoids; Humans; Models, Genetic; Nerve Degeneration; Neuronal Plasticity; Oxidative Stress; Protein Serine-Threonine Kinases; Tumor Suppressor Proteins | 2013 |
5 trial(s) available for betamethasone and Ataxia Telangiectasia
| Article | Year |
|---|---|
Long-Term Evaluation of Low-Dose Betamethasone for Ataxia Telangiectasia.
Topics: Adolescent; Adrenal Gland Diseases; Ataxia Telangiectasia; Betamethasone; Child; Drug-Related Side Effects and Adverse Reactions; Female; Glucocorticoids; Humans; Longitudinal Studies; Male; Outcome Assessment, Health Care; Peripheral Nervous System Diseases | 2019 |
Efficacy of very-low-dose betamethasone on neurological symptoms in ataxia-telangiectasia.
Topics: Adolescent; Anti-Inflammatory Agents; Ataxia Telangiectasia; Betamethasone; Biomarkers; Child; Dose-Response Relationship, Drug; Female; Humans; Male; Receptors, Glucocorticoid; Reverse Transcriptase Polymerase Chain Reaction; Transcription Factors; Treatment Outcome; Young Adult | 2011 |
Steroid treatment in Ataxia-Telangiectasia induces alterations of functional magnetic resonance imaging during prono-supination task.
Topics: Adolescent; Ataxia Telangiectasia; Betamethasone; Child; Female; Glucocorticoids; Humans; Magnetic Resonance Imaging; Male; Motor Cortex; Pilot Projects; Posture; Psychomotor Performance | 2013 |
A randomized trial of oral betamethasone to reduce ataxia symptoms in ataxia telangiectasia.
Topics: Administration, Oral; Adolescent; Anti-Inflammatory Agents; Ataxia Telangiectasia; Betamethasone; Child; Female; Humans; Male; Treatment Outcome | 2012 |
Steroid-induced improvement of neurological signs in ataxia-telangiectasia patients.
Topics: Administration, Oral; Adolescent; Adult; Ataxia Telangiectasia; Betamethasone; Brain; Child; Child, Preschool; Female; Glucocorticoids; Humans; Lymphocytes; Magnetic Resonance Imaging; Male; Monocytes; Time Factors | 2008 |
6 other study(ies) available for betamethasone and Ataxia Telangiectasia
| Article | Year |
|---|---|
In Ataxia-Telangiectasia, Oral Betamethasone Administration Ameliorates Lymphocytes Functionality through Modulation of the IL-7/IL-7Rα Axis Paralleling the Neurological Behavior: A Comparative Report of Two Cases.
Topics: Administration, Oral; Anti-Inflammatory Agents; Ataxia Telangiectasia; Attention Deficit and Disruptive Behavior Disorders; Betamethasone; Child, Preschool; Female; Humans; Interleukin-7; Lymphocyte Activation; Lymphocytes; Male; Microarray Analysis; Receptors, Interleukin-7; Signal Transduction | 2021 |
Minimum effective betamethasone dosage on the neurological phenotype in patients with ataxia-telangiectasia: a multicenter observer-blind study.
Topics: Adolescent; Ataxia Telangiectasia; Betamethasone; Child; Child, Preschool; Dose-Response Relationship, Drug; Female; Glucocorticoids; Humans; Male; Phenotype; Quality of Life; Treatment Outcome; Young Adult | 2018 |
A rat model of ataxia-telangiectasia: evidence for a neurodegenerative phenotype.
Topics: Animals; Anti-Inflammatory Agents; Ataxia Telangiectasia; Ataxia Telangiectasia Mutated Proteins; Betamethasone; Brain; Cells, Cultured; Disease Models, Animal; Humans; Inflammation; Microglia; Neurodegenerative Diseases; Neurons; Phenotype; Rats; Rats, Mutant Strains | 2017 |
A proposed bailout for A-T patients?
Topics: Acquired Immunodeficiency Syndrome; Age Factors; Ataxia Telangiectasia; Ataxia Telangiectasia Mutated Proteins; Betamethasone; Cell Cycle Proteins; Cerebellum; Clinical Trials as Topic; DNA-Binding Proteins; Glucocorticoids; Humans; Immunosuppression Therapy; Oxidative Stress; Protein Serine-Threonine Kinases; Risk Assessment; Time; Time Factors; Treatment Outcome; Tumor Suppressor Proteins | 2009 |
In ataxia-teleangiectasia betamethasone response is inversely correlated to cerebellar atrophy and directly to antioxidative capacity.
Topics: Adolescent; Adult; Anti-Inflammatory Agents; Antioxidants; Ataxia Telangiectasia; Atrophy; Betamethasone; Cells, Cultured; Cerebellar Diseases; Cerebellum; Child; Child, Preschool; Disease Progression; Female; Glutathione; Humans; Lipid Peroxidation; Male; Oxidative Stress; Reactive Oxygen Species; Severity of Illness Index; Treatment Outcome; Young Adult | 2009 |
Betamethasone and improvement of neurological symptoms in ataxia-telangiectasia.
Topics: Ataxia; Ataxia Telangiectasia; Ataxia Telangiectasia Mutated Proteins; Betamethasone; Cell Cycle Proteins; Cerebellum; Child, Preschool; Conjunctiva; DNA-Binding Proteins; Drug Administration Schedule; Drug Therapy, Combination; Gait Disorders, Neurologic; Glucocorticoids; Humans; Male; Methylprednisolone; Protein Serine-Threonine Kinases; Recovery of Function; Treatment Outcome; Tumor Suppressor Proteins | 2006 |